INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Results

82,097 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
8
BR
Bentley Sheldon Richard10% Owner, Founder
CSAICLOUDASTRUCTURE, INC.
Open-market sale · 10b5-1 plan
SELL$26K
25.0K sh
Dec 23, 2025
Page 1805 of 2053
← PrevNext →
Dec 29, 2025
traded Dec 23, 2025
+6d
SEC Form 4

Evidence

8
BR
Bentley Sheldon Richard10% Owner, Founder
CSAICLOUDASTRUCTURE, INC.
Open-market sale · 10b5-1 plan
SELL$26K
25.0K sh
Dec 24, 2025Dec 29, 2025
traded Dec 24, 2025
+5dSEC Form 4

Evidence

7
AA
Ashish AroraDirector, Chief Executive Officer, 10% Owner
CRCTCricut, Inc.
Open-market sale · 10b5-1 plan
SELL$103K
20.8K sh
Dec 24, 2025Dec 29, 2025
traded Dec 24, 2025
+5dSEC Form 4

Evidence

7
AA
Ashish AroraDirector, Chief Executive Officer, 10% Owner
CRCTCricut, Inc.
Open-market sale · 10b5-1 plan
SELL$107K
20.8K sh
Dec 22, 2025Dec 29, 2025
traded Dec 22, 2025
+7dSEC Form 4

Evidence

7
AA
Ashish AroraDirector, Chief Executive Officer, 10% Owner
CRCTCricut, Inc.
Open-market sale · 10b5-1 plan
SELL$104K
20.8K sh
Dec 23, 2025Dec 29, 2025
traded Dec 23, 2025
+6dSEC Form 4

Evidence

5
SS
Skates SpenserDirector, Chief Executive Officer, 10% Owner
AMPLAmplitude, Inc.
Derivative conversion · 10b5-1 plan
C—
42.7K sh
Dec 24, 2025Dec 29, 2025
traded Dec 24, 2025
+5dSEC Form 4

Evidence

5
LF
Lo FrancisChief People Officer
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
1,100 sh
Dec 22, 2025Dec 29, 2025
traded Dec 22, 2025
+7dSEC Form 4

Evidence

5
LF
Lo FrancisChief People Officer
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$8,580
1,100 sh
Dec 22, 2025Dec 29, 2025
traded Dec 22, 2025
+7dSEC Form 4

Evidence

5
LF
Lo FrancisChief People Officer
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$4,389
1,100 sh
Dec 22, 2025Dec 29, 2025
traded Dec 22, 2025
+7dSEC Form 4

Evidence

5
FA
Flees Lori AnnDirector, President & CEO
VVVVALVOLINE INC
Grant or award
A$1,775
59 sh
Dec 26, 2025Dec 29, 2025
traded Dec 26, 2025
+3dSEC Form 4

Evidence

5
LF
Lo FrancisChief People Officer
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
2,194 sh
Dec 22, 2025Dec 29, 2025
traded Dec 22, 2025
+7dSEC Form 4

Evidence

5
RE
Rote William E.Chief Research Officer
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
60.0K sh
Dec 24, 2025Dec 29, 2025
traded Dec 24, 2025
+5dSEC Form 4

Evidence

5
LF
Lo FrancisChief People Officer
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
1,100 sh
Dec 22, 2025Dec 29, 2025
traded Dec 22, 2025
+7dSEC Form 4

Evidence

5
LF
Lo FrancisChief People Officer
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$19K
2,194 sh
Dec 22, 2025Dec 29, 2025
traded Dec 22, 2025
+7dSEC Form 4

Evidence

4
WC
Wren ChrisVP of Operations
PLNHPlanet 13 Holdings Inc.
Open-market sale · 10b5-1 plan
SELL$6,849
30.0K sh
Dec 24, 2025Dec 29, 2025
traded Dec 24, 2025
+5dSEC Form 4

Evidence

4
Dines DanielDirector, CEO and Chairman, 10% Owner
PATHUiPath, Inc.
Open-market sale · 10b5-1 plan
SELL$740K
45.0K sh
Dec 29, 2025Dec 29, 2025
traded Dec 29, 2025
+0dSEC Form 4

Evidence

4
RM
Rizik MatthewDirector
RKTRocket Companies, Inc.
Open-market sale · 10b5-1 plan
SELL$49K
2,500 sh
Dec 24, 2025Dec 29, 2025
traded Dec 24, 2025
+5dSEC Form 4

Evidence

4
RM
Rizik MatthewDirector
RKTRocket Companies, Inc.
Open-market sale · 10b5-1 plan
SELL$47K
2,500 sh
Dec 23, 2025Dec 29, 2025
traded Dec 23, 2025
+6dSEC Form 4

Evidence

4
BS
Beatty Jonathan SMD, Head of Advisor Services
SCHWSCHWAB CHARLES CORP
Option exercise · 10b5-1 plan
M$93K
2,000 sh
Dec 23, 2025Dec 29, 2025
traded Dec 23, 2025
+6dSEC Form 4

Evidence

4
Dines DanielDirector, CEO and Chairman, 10% Owner
PATHUiPath, Inc.
Open-market sale · 10b5-1 plan
SELL$761K
45.0K sh
Dec 26, 2025Dec 29, 2025
traded Dec 26, 2025
+3dSEC Form 4

Evidence

3
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Derivative conversion · 10b5-1 plan
C—
800.0K sh
Dec 26, 2025Dec 29, 2025
traded Dec 26, 2025
+3dSEC Form 4

Evidence

2
SB
Slowe Christopher BrianChief Technology Officer
RDDTReddit, Inc.
Derivative conversion · 10b5-1 plan
C—
12.0K sh
Dec 22, 2025Dec 29, 2025
traded Dec 22, 2025
+7dSEC Form 4

Evidence

1
SS
Skates SpenserDirector, Chief Executive Officer, 10% Owner
AMPLAmplitude, Inc.
Derivative conversion · 10b5-1 plan
C—
42.7K sh
Dec 24, 2025Dec 29, 2025
traded Dec 24, 2025
+5dSEC Form 4

Evidence

1
BS
Beatty Jonathan SMD, Head of Advisor Services
SCHWSCHWAB CHARLES CORP
Option exercise · 10b5-1 plan
M—
2,000 sh
Dec 23, 2025Dec 29, 2025
traded Dec 23, 2025
+6dSEC Form 4

Evidence

0
SB
Slowe Christopher BrianChief Technology Officer
RDDTReddit, Inc.
Derivative conversion · 10b5-1 plan
C—
12.0K sh
Dec 22, 2025Dec 29, 2025
traded Dec 22, 2025
+7dSEC Form 4

Evidence

0
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
281.3K sh
Dec 24, 2025Dec 29, 2025
traded Dec 24, 2025
+5dSEC Form 4

Evidence

0
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
281.3K sh
Dec 24, 2025Dec 29, 2025
traded Dec 24, 2025
+5dSEC Form 4

Evidence

0
SB
Slowe Christopher BrianChief Technology Officer
RDDTReddit, Inc.
Option exercise · 10b5-1 plan
M—
12.0K sh
Dec 22, 2025Dec 29, 2025
traded Dec 22, 2025
+7dSEC Form 4

Evidence

0
RM
Rizik MatthewDirector
RKTRocket Companies, Inc.
Open-market sale · 10b5-1 plan
SELL$48K
2,500 sh
Dec 26, 2025Dec 29, 2025
traded Dec 26, 2025
+3dSEC Form 4

Evidence

54
LY
Louie Ngar YeeDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$111K
81.7K sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC Form 4

Evidence

54
CM
Chaouki Steven MDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$56K
40.8K sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC Form 4

Evidence

51
FF
Flannery FionaDirector
GFNEW GERMANY FUND INC
Open-market purchase
BUY$10K
872 sh
Dec 15, 2025Dec 23, 2025
traded Dec 15, 2025
+8dSEC Form 4

Evidence

48
ZN
Zojwalla NaseemChief Medical Officer
OLMAOlema Pharmaceuticals, Inc.
Open-market sale
SELL$2.75M
99.5K sh
Dec 23, 2025Dec 23, 2025
traded Dec 23, 2025
+0dSEC Form 4

Evidence

48
ZN
Zojwalla NaseemChief Medical Officer
OLMAOlema Pharmaceuticals, Inc.
Open-market sale
SELL$1.60M
57.1K sh
Dec 19, 2025Dec 23, 2025
traded Dec 19, 2025
+4dSEC Form 4

Evidence

48
ZN
Zojwalla NaseemChief Medical Officer
OLMAOlema Pharmaceuticals, Inc.
Open-market sale
SELL$2.80M
100.0K sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC Form 4

Evidence

47
SS
Smith StanDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$78K
57.2K sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC Form 4

Evidence

47
CM
Chaouki Steven MDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$50K
40.8K sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC Form 4

Evidence

46
LY
Louie Ngar YeeDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$100K
81.7K sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC Form 4

Evidence

45
SM
Sentonas MichaelPRESIDENT
CRWDCrowdStrike Holdings, Inc.
Open-market sale
SELL$5.50M
11.5K sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC Form 4

Evidence

44
MC
Myles David C.CH. DISCOV. & NON-CLIN DEV OFF
OLMAOlema Pharmaceuticals, Inc.
Open-market sale
SELL$1.33M
43.7K sh
Dec 19, 2025Dec 23, 2025
traded Dec 19, 2025
+4dSEC Form 4

Evidence